*Median represents the median of each surgeon’s median OMEs prescribed. After excluding the highest volume surgeon for prostatectomy (A) and nephrectomy (B) and after excluding the co-principal investigators for prostatectomy (C) and nephrectomy (D), the median OMEs prescribed among surgeons remained significantly decreased between the pre-intervention phase and intervention phase as well as between the pre-intervention phase and wash-out phase (all p
*Median represents the median of each surgeon’s median OMEs prescribed. After excluding the highest volume surgeon for prostatectomy (A) and nephrectomy (B) and after excluding the co-principal investigators for prostatectomy (C) and nephrectomy (D), the median OMEs prescribed among surgeons remained significantly decreased between the pre-intervention phase and intervention phase as well as between the pre-intervention phase and wash-out phase (all p
Figure 1.. Median* oral morphine equivalents (OMEs)…
Figure 1.. Median* oral morphine equivalents (OMEs) prescribed for patients undergoing prostatectomy (A) and nephrectomy…
Figure 1.. Median* oral morphine equivalents (OMEs) prescribed for patients undergoing prostatectomy (A) and nephrectomy (B) *Median represents the median of each surgeon’s median OMEs prescribed. The median OMEs prescribed among surgeons decreased significantly between the pre-intervention phase and intervention phase as well as between the intervention phase and wash-out phase for both prostatectomy (Figure 1A; both p=0.01; Wilcoxon sign-rank test with Bonferroni correction) and nephrectomy (Figure 1B; both p=0.01; Wilcoxon sign-rank test with Bonferroni correction). Specifically, the median OMEs decreased from 195 to 19 in the prostatectomy patients and from 200 to 0 in the nephrectomy patients. There is no significant difference in the median OMEs prescribed during the intervention and wash-out phases. Error bars represent the 95% confidence intervals.
Figure 1.. Median* oral morphine equivalents (OMEs)…
Figure 1.. Median* oral morphine equivalents (OMEs) prescribed for patients undergoing prostatectomy (A) and nephrectomy…
Figure 1.. Median* oral morphine equivalents (OMEs) prescribed for patients undergoing prostatectomy (A) and nephrectomy (B) *Median represents the median of each surgeon’s median OMEs prescribed. The median OMEs prescribed among surgeons decreased significantly between the pre-intervention phase and intervention phase as well as between the intervention phase and wash-out phase for both prostatectomy (Figure 1A; both p=0.01; Wilcoxon sign-rank test with Bonferroni correction) and nephrectomy (Figure 1B; both p=0.01; Wilcoxon sign-rank test with Bonferroni correction). Specifically, the median OMEs decreased from 195 to 19 in the prostatectomy patients and from 200 to 0 in the nephrectomy patients. There is no significant difference in the median OMEs prescribed during the intervention and wash-out phases. Error bars represent the 95% confidence intervals.
Figure 2.. Median oral morphine equivalents prescribed…
Figure 2.. Median oral morphine equivalents prescribed per surgeon for patients undergoing prostatectomy (A) and…
Figure 2.. Median oral morphine equivalents prescribed per surgeon for patients undergoing prostatectomy (A) and nephrectomy (B) The median oral morphine equivalents prescribed per surgeon are decreasing for both prostatectomy (A) and nephrectomy (B) patients. By the end of the study, 40% and 60% of the attending surgeons prescribed a median of 0 oral morphine equivalents for prostatectomy and nephrectomy, respectively. Of note, if a given surgeon did not perform a procedure in a given month, then the data point for that month will be missing, making the line discontinuous.
Figure 2.. Median oral morphine equivalents prescribed…
Figure 2.. Median oral morphine equivalents prescribed per surgeon for patients undergoing prostatectomy (A) and…
Figure 2.. Median oral morphine equivalents prescribed per surgeon for patients undergoing prostatectomy (A) and nephrectomy (B) The median oral morphine equivalents prescribed per surgeon are decreasing for both prostatectomy (A) and nephrectomy (B) patients. By the end of the study, 40% and 60% of the attending surgeons prescribed a median of 0 oral morphine equivalents for prostatectomy and nephrectomy, respectively. Of note, if a given surgeon did not perform a procedure in a given month, then the data point for that month will be missing, making the line discontinuous.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.
Figure 3.. Patient reported outcomes using the…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and…
Figure 3.. Patient reported outcomes using the International Pain Outcomes questionnaire for prostatectomy (A-D) and nephrectomy (E-H) Prostatectomy patients discharged with opioids had higher levels of anxiety than patients discharged without opioids (p0.05; two-sample t-test). The questions are scored on a 0-10 scale, where 0 indicates no symptoms and 10 indicates severe symptoms.